Go to Content Go to Navigation Go to Navigation Go to Site Search Homepage

ADVISORY: Family Planning Press Conference - Thurs 2/1



January 30, 2018

Contact: Casey Olesko 201.647.5502 / [email protected]

Reproductive health advocates urge New Jersey State Legislature to vote ‘yes’ for women’s health

Planned Parenthood New Jersey supporters to join legislative leaders for press conference before Senate vote to restore family planning funding

TRENTON, NJ — On Thursday, Feb. 1, the New Jersey Senate will vote on a family planning funding restoration bill. The legislation would reinstate the $7.45 million cut from reproductive health care services by former Governor Christie. Planned Parenthood Action Fund of New Jersey supporters, staff, and volunteers will join legislative leaders for a press conference at the State House in Trenton to underscore how critical these funds are to women’s health.

WHAT: Press conference on family planning funding restoration vote

WHEN: Thursday, February 1, 2018 at 11:30am

WHERE: New Jersey State House, Room 103


Christine Sadovy, Legislative and Political Director, Planned Parenthood Action Fund of NJ

Senate Majority Leader Loretta Weinberg

Senate President Steve Sweeney

Senator Kip Bateman

Assembly Speaker Craig Coughlin

Assemblyman Vince Mazzeo

Assemblywoman Eliana Pintor Marin

Assemblywoman Joann Downey

Planned Parenthood supporters and staff will be available for interviews, photo and video. Please contact [email protected] to coordinate (201-647- 5502).

Since the cuts, there have been dramatic statewide increases in bacterial STDs and breast and cervical cancer cases. Restoring funding for family planning will be a first step toward restoring the health of New Jersey women and families.

The New Jersey Legislature voted to restore family planning funding numerous times during the previous administration. However, former Governor Christie repeatedly vetoed those bills. Governor Murphy has promised to sign the legislation that will support critical health services, including cancer screenings and testing and treatment for sexually transmitted diseases (STDs).